News & Press Releases
Filter by:
Mintz advised the underwriters in connection with InflaRx’s $150 million underwritten offering of ordinary shares.
Mintz advised the underwriters in connection with Avalo Therapeutics’ $431.3 million public offering of common stock and pre-funded warrants.
Robert Vlasis shared insights in a Law360 article about the U.S. International Trade Commission’s proposed rule requiring disclosure of litigation funding in intellectual property cases.
Michelle Capezza was quoted in a Fiduciary News article examining why the 401(k) start-up tax credit is underutilized by small employers.
Mintz advised Axoft, a neurotechnology company, on a $55 million Series A financing round. The funding will be used to expand Axoft’s clinical trials globally and progress US regulatory approval for its implantable Brain-Computer Interfaces (iBCIs).
Mintz has been recognized by US News & World Report as a 2026 Best Company to Work For among US law firms, marking the third consecutive year the firm has earned this distinction.
